Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hong, Z; Hong, F; Olschewski, A; Cabrera, JA; Varghese, A; Nelson, DP; Weir, EK.
Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus.
CIRCULATION. 2006; 114: 1372-1379.
Doi: 10.1161/CIRCULATIONAHA.106.641126
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Olschewski Andrea
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: At birth, the increase in oxygen causes contraction of the ductus arteriosus, thus diverting blood flow to the lungs. Although this contraction is modulated by substances such as endothelin and dilator prostaglandins, normoxic contraction is an intrinsic property of ductus smooth muscle. Normoxic inhibition of potassium channels causes membrane depolarization and calcium entry through L-type calcium channels. However, the studies reported here show that after inhibition of this pathway there is still substantial normoxic contraction, indicating the involvement of additional mechanisms. METHODS AND RESULTS: Using ductus ring experiments, calcium imaging, reverse-transcription polymerase chain reaction, Western blot, and cellular electrophysiology, we find that this depolarization-independent contraction is caused by release of calcium from the IP3-sensitive store in the sarcoplasmic reticulum, by subsequent calcium entry through store-operated channels, and by increased calcium sensitization of actin-myosin filaments, involving Rho-kinase. CONCLUSIONS: Much of the normoxic contraction of the ductus arteriosus at birth is related to calcium entry through store-operated channels, encoded by the transient receptor potential superfamily of genes, and to increased calcium sensitization. A clearer understanding of the mechanisms involved in normoxic contraction of the ductus will permit the development of better therapy to close the patent ductus arteriosus, which constitutes approximately 10% of all congenital heart disease and is especially common in premature infants.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Arachidonic Acids - pharmacology
- Boron Compounds - pharmacology
- Calcium - pharmacology
- Calcium Channel Blockers - pharmacology
- Calcium Channels, L-Type - drug effects
- Calcium Signaling - physiology
- Cytosol - metabolism
- Ductus Arteriosus - embryology
- Imidazoles - pharmacology
- In Vitro - pharmacology
- Indoles - pharmacology
- Intracellular Signaling Peptides and Proteins - physiology
- Isoquinolines - pharmacology
- Maleimides - pharmacology
- Menthol - pharmacology
- Mibefradil - pharmacology
- Muscle Contraction - drug effects
- Nifedipine - pharmacology
- Niflumic Acid - pharmacology
- Oxidation-Reduction - pharmacology
- Oxygen - pharmacology
- Patch-Clamp Techniques - pharmacology
- Potassium Channels - drug effects
- Protein-Serine-Threonine Kinases - physiology
- Rabbits - embryology
- Research Support, N.I.H., Extramural - embryology
- Research Support, U.S. Gov't, Non-P.H.S. - embryology
- Ruthenium Red - pharmacology
- Sulfonamides - pharmacology
- Tetraethylammonium - pharmacology
- Thapsigargin - pharmacology
- Thiourea - analogs and derivatives
- Find related publications in this database (Keywords)
- ductus arteriosus
- patent
- heart defects
- congenital
- ion channels
- oxygen
- vasoconstriction